Compare Fubotv Inc (FUBO) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fubotv Inc vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Fubotv Inc trades at $8.22 (market cap $894.32M), while GE HealthCare Technologies Inc. Common Stock trades at $68.97 (market cap $31.07B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 34.7× Fubotv Inc's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Fubotv Inc pays none. Which is the better fit depends on your goals.
| FUBO | GEHC | |
|---|---|---|
Market Cap | $894.32M | $31.07B |
Volume | 1,279,134 | 3,443,020 |
Sector | Media | Health |
52-Week High | $48.96 | $88.16 |
52-Week Low | $8.09 | $59.48 |
Typical Hold Time | 35 Days | — |
Enterprise Value | $1.07B | $39.53B |
Dividend Yield | — | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FUBO stock trades at $8.19, down 6.29% today, reflecting a bearish technical signal. Revenue grew to $1.62 billion in 2024, with net losses narrowing to -$172.25 million, indicating improving profitability trends. The company recently expanded sports streaming partnerships, including a multi-year NHL deal announced September 28, 2026, to enhance content offerings.
The outlook is mixed; deep undervaluation metrics like P/S of 0.16 and analyst consensus price target of $63.38 suggest significant upside, but persistent cash burn and competitive pressures in streaming pose risks. Investor sentiment hinges on execution of Disney-backed turnaround plans targeting $300 million EBITDA by FY28.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Fubotv Inc
FuboTV Inc is a sports-first, live TV streaming company, offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, fuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. The company offer subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality best suited to their preferences. The operating segments of the group are Streaming and Online wagering, of which a majority of revenue is derived from the Streaming segment. It has a business presence in the U.S. and other international countries.
Read more on FUBO →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
